hsBCL9CT-24 - Immunology - Antigens/Epitotes/Pools/Librairies
Blocks the Wnt pathway and inhibits the expression of TGFb1 in CT26 colon carcinoma cells, leading to the reduction of CCL20 and CCL22, two TGF-b- dependent chemokines critical for Treg cell recruitment into the tumour microenvironment. hsBCL9CT-24 shows robust antitumour efficacy across multiple in vivo models.
Technical specification
 |
Sequence : | [Stp(6,10)]Ac-LQTLR(S5)IQR(S5)L(2Nal)-NH2, 2Nal is 2-naphthyl-alalnine |
 |
MW : | 1.628 g/mol |
 |
Purity : | > 95% |
 |
Counter-Ion : | TFA Salts |
 |
Delivery format : | Lyophilized |
Price
| Product | Size | Price € | Price $ |
| CRB1001394-1 mg | 1 mg | 489€ | 587$ |
